R&D informatics

Develop custom algorithms and apply machine learning to create an integrated and harmonized source of data. Elsevier can help with:
Data integration and harmonization
Workflow solutions
Text-mining applications
Cheminformatics
很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。
我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法 打開新的分頁/視窗
您需要值得信賴的合作夥伴來應對複雜的數據挑戰並改善創新成果。愛思唯爾專業服務是一支敏捷的顧問團隊,支援定製數據集成和應用分析。與愛思唯爾一起走得更遠、更快。
Develop custom algorithms and apply machine learning to create an integrated and harmonized source of data. Elsevier can help with:
Data integration and harmonization
Workflow solutions
Text-mining applications
Cheminformatics
Develop custom reports to answer key R&D and safety questions. Elsevier can help answer questions such as:
Which studies have been conducted for similar compounds and what were the findings?
What adverse events might occur based on molecular structure and class?
What are the most predictive preclinical species for understanding human toxicity?
What is the potential risk of litigation based on drug failure?
Accelerate early discovery activities through access to critical disease or target overview information to prioritize research focus areas. Elsevier can help you answer key research questions, such as:
Which diseases might this target treat?
What are the potential adverse events and drug interactions?
Are there known molecules likely to be test molecules?
What new target may exist to treat a specific disease with less side effects?
How does each target score based on pathway activation, gene expression, and an overall literature analysis?
Develop a more thorough understanding of the chemical risk of a compound based on the analysis of biological pathways in the human body and underlying molecular mechanisms that can cause diseases. Our team can help answer questions such as:
What are the key cells to target for a particular disease?
Which proteins are relevant in my disease of interest?
What are the biomarkers on the path to toxicity?
Which molecular mechanisms are linked to disease outcomes?
Access detailed custom reports and predictive analytics to support critical drug repurposing decisions. These solutions include:
Text mining for possible drug indications in the scientific literature
Prediction of new drug indications based on drug target biology and efficacy of other drugs in the same class
Scoring mechanism to identify most promising repurposing candidates
Disease-centric repurposing includes pathway analysis to identify:
Signaling affected in a disease
Compounds targeting proteins in the disease pathway
Known drugs to inhibit proteins
利用Elsevier的專業服務和一系列解決方案來支援和優化創新成果,推進您的研發。在以下支援下,自信地導航您的研發之旅:
從同行評審的科學文獻到監管數據的可信內容
為機器使用準備數據的創新技術
以計算格式捕獲科學知識的專業知識
資訊完整性對您的進步至關重要。發現將複雜性轉化為科學見解的可信數據和工具。讓我們共同塑造進步。